Nadav Kidron - 31 Aug 2021 Form 4/A - Amendment Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role
President and CEO, Director
Signature
/s/ Nadav Kidron
Issuer symbol
ORMP
Transactions as of
31 Aug 2021
Net transactions value
$0
Form type
4/A - Amendment
Filing time
07 Dec 2021, 15:30:29 UTC
Date Of Original Report
02 Sep 2021
Previous filing
07 Dec 2021
Next filing
07 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORMP Common Stock Award +100,000 +14% 838,209 31 Aug 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Stock Units ("RSUs") granted in February 2021 and vested upon achievement of certain vesting conditions. The RSUs convert into Issuer's common stock on a one-for-one basis.
F2 This amendment is being filed to correct an administrative error in Form 4 filed by Mr. Kidron, which reported that 748,573 shares of common stock are beneficially owned by him following the reported transaction. Mr. Kidron beneficially owned 838,209 shares of common stock following the reported transaction.